logo
Select company
Select metric
$ 125.92MInvested Capital
VS
Market
29
Sector
49
Industry
52
History
14
$ 1.67Close
$ 1.51 - $ 9.22 52-Week Range
Ticker Information

Ticker

LUNG

Company Name

PULMONX CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

PULMONX CORP - Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LUNG - Inv. Capital Historical data
DateTotal DebtShareholders EquityInvested Capital
6/30/2025$ 56.83M$ 69.09M$ 125.92M
3/31/2025$ 56.95M$ 77.67M$ 134.62M
12/31/2024$ 56.47M$ 85.81M$ 142.28M
9/30/2024$ 55.81M$ 93.92M$ 149.73M
6/30/2024$ 56.19M$ 101.18M$ 157.37M
3/31/2024$ 40.57M$ 110.5M$ 151.07M
12/31/2023$ 41.42M$ 118.31M$ 159.74M
9/30/2023$ 42.22M$ 125.74M$ 167.96M
6/30/2023$ 42.99M$ 133.95M$ 176.94M
3/31/2023$ 43.58M$ 143.93M$ 187.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PULMONX CORP's latest trailing twelve months (TTM) Inv. Capital stands at $ -149.66M.
  • Over the past 5 years, PULMONX CORP's average Inv. Capital has been $ 167.97M.
  • The median Inv. Capital for PULMONX CORP during this period was $ 177.68M
  • PULMONX CORP reached its highest Inv. Capital over the past 5 years at $ 253.36M.
  • The lowest Inv. Capital recorded by PULMONX CORP in the same timeframe $ -149.66M

PULMONX CORP's Inv. Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. Capital Benchmarks
CompanyInv. Capital
TELA : TELA BIO INC $ 50.57MMYO : MYOMO INC $ 30.05MAPYX : APYX MEDICAL CORP $ 46.33MXTNT : XTANT MEDICAL HOLDINGS INC $ 85.58MBDSX : BIODESIX INC $ 73.28MSRTS : SENSUS HEALTHCARE INC $ 52.66MCTSO : CYTOSORBENTS CORP $ 38.15MSTRO : SUTRO BIOPHARMA INC $ -12.52MANIK : ANIKA THERAPEUTICS INC $ 170.84MMDAI : SPECTRAL AI INC $ 497K

Definition of Invested Capital

[Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
Debt + Equity
(=) Inv. Capital
Inv. Capital for PULMONX CORP is calculated as follows: Debt [ $ 57.23M ] + Equity [ $ -206.89M ]
(=) Inv. Capital [ $ -149.66M ]

LUNG - Invested Capital, Last 5 years

$ -149.66M

Minimum

Sep 30, 2020

$ 253.36M

Maximum

Dec 31, 2020

$ 167.97M

Average

$ 177.68M

Median

Inv. Capital Benchmark Analysis

The chart above depicts the distribution of Inv. Capital for companies in the Total Stock Market. The average Inv. Capital of the companies is $ 759.87M with a standard deviation of $ 1B.
The following table provides additional summary stats:
Inv. Capital in the Market:
filtered constituents3.44K
min$ -1.51B
max$ 4.11B
average$ 759.87M
median$ 302.55M
std$ 1B